Pediatricians face difficulty as parents push for kids under 12 to get vaccinated


Some pediatricians are under pressure as parents insist that children under 12 be vaccinated

As of now, children 12 and older can be vaccinated against COVID-19, but apparently that doesn’t stop many parents of kids 11 and under from putting pressure on their pediatricians.

WASHINGTON (FOX 5 DC) – As of now, children 12 and older can be vaccinated against COVID-19, but apparently that doesn’t stop many parents of kids 11 and under from putting pressure on their pediatrician.

Download the FOX 5 DC News app for local news and weather

“Many parents have reached out to their pediatrician to see if the vaccine could be available to their children off-label,” explains Dr. Lee Beers, president of the American Academy of Pediatrics. “We also feel the urgency to have a vaccine available for children under the age of 12, but we also know that it is very important to follow FDA guidelines and to follow the policies and procedures in place to to ensure that we have a safe and effective vaccine.”

As previously reported by The Washington Post, the problem is so widespread that the American Academy of Pediatrics posted a warning on their website earlier this week, and the CDC also posted about the problem.

Beers said that in addition to the fact that the FDA has not yet approved the vaccine for younger children, other problems arise. She said doctors are opening themselves up to problems if they find out about the so-called off-label use of vaccines, including possible lawsuits. Also, experts still don’t fully understand how the vaccine will affect young children.

MORE FROM FOX 5: President Biden Announces Plan for Pay Increases for Federal Workers

“There are reasons that we are going through these very careful trials to determine the right dose for safety and efficacy, and it appears that the dose for younger children will be lower than for adolescents and adults,” Beers added.

As for when the vaccine will be available for children under 12, Beers said the AAP is urging the FDA to act as soon as possible, adding that it has heard estimates ranging from mid-fall to early winter.

Comments are closed.